Page 93 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initiated coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initiated Coverage Today - Breaking & Trending Today

Manhattan Bridge Capital (NASDAQ:LOAN) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Manhattan Bridge Capital (NASDAQ:LOAN – Free Report) in a research note published on Thursday. The brokerage issued a strong-buy rating on the credit services provider’s stock. Manhattan Bridge Capital Stock Performance NASDAQ LOAN opened at $5.06 on Thursday. The stock’s fifty day moving average is $4.92 and its two-hundred […] ....

United States , Pinnacle Wealth Planning Services Inc , Soltis Investment Advisors , Melia Wealth , Hardy Reed , Capital Inc , International Assets Investment Management , Manhattan Bridge Capital , Free Report , Bridge Capital , Assets Investment Management , Investment Advisors , Wealth Planning Services , Get Free Report , Manhattan Bridge Capital Daily , Nasdaq Loan , Initiated Coverage , Stocknews Com ,

StockNews.com Begins Coverage on S&W Seed (NASDAQ:SANW)

StockNews.com started coverage on shares of S&W Seed (NASDAQ:SANW – Free Report) in a report issued on Tuesday morning. The brokerage issued a sell rating on the stock. S&W Seed Trading Down 2.8 % SANW stock opened at $0.42 on Tuesday. The company has a market capitalization of $18.16 million, a PE ratio of 1.50 […] ....

United States , Wynnefield Capital Inc , Sw Seed Company Profile , Sw Seed Company , Securities Exchange Commission , Free Report , Get Free Report , Wynnefield Capital , Sw Seed , Nasdaq Sanw , Consumer Staple , Initiated Coverage , Stocknews Com ,

Tenable (NASDAQ:TENB) Coverage Initiated at Scotiabank

Scotiabank began coverage on shares of Tenable (NASDAQ:TENB – Get Free Report) in a note issued to investors on Friday, Briefing.com reports. The firm set a “sector perform” rating and a $47.00 price target on the stock. Scotiabank’s target price indicates a potential upside of 3.57% from the company’s current price. Several other analysts have […] ....

Asia Pacific , Stephena Vintz , Mackenzie Financial Corp , Vanguard Group Inc , Tenable Holdings Inc , Tenable Company Profile , Needham Company , William Blair Investment Management , Tenable Security Center , First Trust Advisors , Westfield Capital Management Co , Securities Exchange Commission , Get Free Report , Truist Financial , Exchange Commission , Trust Advisors , Financial Corp , Blair Investment Management , Westfield Capital Management , Capital Management , Middle East , Tenable Vulnerability Management , Tenable Cloud Security , Tenable Identity Exposure , Active Directory , Tenable Web App Scanning ,

Lloyds Banking Group (NYSE:LYG) Coverage Initiated by Analysts at Berenberg Bank

Berenberg Bank began coverage on shares of Lloyds Banking Group (NYSE:LYG – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued a hold rating and a $2.75 price target on the financial services provider’s stock. Separately, Bank of America raised Lloyds Banking Group from a neutral rating to a buy […] ....

United States , United Kingdom , Analyst Recommendations For Lloyds Banking Group , Patriot Financial Group Insurance Agency , Lloyds Banking Group , News Ratings For Lloyds Banking Group Daily , Ballentine Partners , Institutional Trading Of Lloyds Banking Group , Lloyds Banking Group Stock Down , Berenberg Bank , Lloyds Banking Group Cuts Dividend , Sterling Financial Group Inc , Barclays Plc , Free Report , Banking Group Stock Down , Banking Group , Get Free Report , Lloyds Banking , Financial Group , Financial Group Insurance Agency , Commercial Banking , Lloyds Banking Group Daily , Nyse Lyg , Initiated Coverage ,

Nabriva Therapeutics (NASDAQ:NBRV) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note published on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Nabriva Therapeutics has a 52 week low of $1.22 and a 52 week high of $8.45. The company has a debt-to-equity […] ....

Nabriva Therapeutics Company Profile , Nabriva Therapeutics , Free Report , Get Free Report , Nabriva Therapeutics Daily , Nasdaq Nbrv , Initiated Coverage , Stocknews Com ,